The eIF2B-interacting domain of RGS2 protects against GPCR agonist-induced hypertrophy in neonatal rat cardiomyocytes.
Chidiac, Peter
The eIF2B-interacting domain of RGS2 protects against GPCR agonist-induced hypertrophy in neonatal rat cardiomyocytes. [electronic resource] - Cellular signalling Jun 2014 - 1226-34 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-3913
10.1016/j.cellsig.2014.02.006 doi
Animals
Animals, Newborn
Cardiomegaly--metabolism
Cell Size--drug effects
Cells, Cultured
Cyclic AMP--metabolism
Eukaryotic Initiation Factor-2B
Gene Expression
Inositol Phosphates--metabolism
Isoproterenol--pharmacology
Myocytes, Cardiac--drug effects
Phenylephrine--pharmacology
Protein Biosynthesis
Protein Interaction Domains and Motifs
RGS Proteins--chemistry
Rats
Receptors, G-Protein-Coupled--agonists
Second Messenger Systems
The eIF2B-interacting domain of RGS2 protects against GPCR agonist-induced hypertrophy in neonatal rat cardiomyocytes. [electronic resource] - Cellular signalling Jun 2014 - 1226-34 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-3913
10.1016/j.cellsig.2014.02.006 doi
Animals
Animals, Newborn
Cardiomegaly--metabolism
Cell Size--drug effects
Cells, Cultured
Cyclic AMP--metabolism
Eukaryotic Initiation Factor-2B
Gene Expression
Inositol Phosphates--metabolism
Isoproterenol--pharmacology
Myocytes, Cardiac--drug effects
Phenylephrine--pharmacology
Protein Biosynthesis
Protein Interaction Domains and Motifs
RGS Proteins--chemistry
Rats
Receptors, G-Protein-Coupled--agonists
Second Messenger Systems